Atara Biotherapeutics shares are trading higher. The company announced a $36 million registered direct offering of 758900 shares at $8.25 per share.
Portfolio Pulse from Benzinga Newsdesk
Atara Biotherapeutics shares rose following the announcement of a $36 million registered direct offering of 758,900 shares at $8.25 each.
September 03, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Atara Biotherapeutics shares increased after the company announced a $36 million registered direct offering, selling 758,900 shares at $8.25 each.
The announcement of a direct offering often indicates investor confidence and can provide the company with necessary capital. The share price increase suggests a positive market reaction to the offering terms.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100